Genetically modified rat comprising a humanized
Non-human animal genomes, non-human animal cells, and non-human animals comprising a humanized TRKB locus and methods of making and using such non-human animal genomes, non-human animal cells, and non-human animals are provided. Non-human animal cells or non-human animals comprising a humanized TRKB locus express a human TRKB protein or a chimeric transthyretin protein, fragments of which are from human TRKB. Methods are provided for using such non-human animals comprising a humanized TRKB locus to assess in vivo efficacy of human-TRKB-targeting reagents such as nuclease agents designed to target human TRKB.
1. A genetically modified rat whose genome comprises a genetically modified endogenous rat TrkB locus comprising a humanized TrkB gene comprising a replacement of an endogenous rat TrkB genomic sequence encoding a rat tropomyosin receptor kinase B (TRKB) protein extracellular domain with a corresponding human TRKB genomic sequence encoding a human TRKB protein extracellular domain,
wherein the endogenous rat TrkB genomic sequence comprises a region starting from the codon in exon 2 encoding amino acid 32 through exon 10, including all introns between exons 2 and 10,
wherein the corresponding human TRKB genomic sequence comprises a region starting from the codon in exon 2 encoding amino acid 32 through exon 10, including all introns between exons 2 and 10,
wherein the humanized TrkB gene encodes:
a humanized TRKB protein comprising:
an endogenous rat TRKB protein signal peptide;
the human TRKB protein extracellular domain;
an endogenous rat TRKB protein transmembrane domain; and
an endogenous rat TRKB protein cytoplasmic domain,
wherein the humanized TRKB protein comprises the sequence set forth in SEQ ID NO: 5,
wherein the humanized endogenous TrkB gene is under the control of an endogenous rat TrkB promoter at the genetically modified endogenous rat TrkB locus,
wherein the rat expresses the humanized TRKB protein,
wherein the rat is homozygous for the genetically modified endogenous rat TrkB locus, and
wherein treatment of the rat with a human TRKB agonist antibody results in a neuroprotective effect on retinal ganglion cell viability after optic nerve injury.
2. The genetically modified rat of claim 1 , wherein the humanized TRKB protein is encoded by the nucleotide sequence set forth in SEQ ID NO: 13.
3. A method of assessing activity of a human-TRKB-targeting reagent in vivo, comprising:
(a) administering the human-TRKB-targeting reagent to the genetically modified rat of claim 1 ; and
(b) assessing the activity of the human-TRKB-targeting reagent in the genetically modified rat of step (a) as compared to an untreated control rat.
4. An isolated rat cell of the genetically modified rat of claim 1 , wherein the rat cell's genome comprises the genetically modified endogenous rat TrkB locus comprising the humanized TrkB gene comprising the replacement of the endogenous rat TrkB genomic sequence encoding the rat TRKB protein extracellular domain with the corresponding human TRKB genomic sequence encoding the human TRKB protein extracellular domain, wherein the cell expresses the humanized TRKB protein.
5. The genetically modified rat of claim 1 , wherein the human TRKB protein extracellular domain is encoded by the nucleotide sequence set forth in SEQ ID NO: 72.
6. The genetically modified rat of claim 1 , wherein the endogenous rat TRKB protein signal peptide is encoded by the nucleotide sequence set forth in SEQ ID NO: 67.
7. The genetically modified rat of claim 1 , wherein the endogenous rat TRKB protein transmembrane domain is encoded by the nucleotide sequence set forth in SEQ ID NO: 69.
8. The genetically modified rat of claim 1 , wherein the endogenous rat TRKB protein cytoplasmic domain is encoded by the nucleotide sequence set forth in SEQ ID NO: 70.
9. The genetically modified rat of claim 1 , wherein the endogenous rat TRKB protein signal peptide is encoded by the nucleotide sequence set forth in SEQ ID NO: 67, the endogenous rat TRKB protein transmembrane domain is encoded by the nucleotide sequence set forth in SEQ ID NO: 69, and the endogenous rat TRKB protein cytoplasmic domain is encoded by the nucleotide sequence set forth in SEQ ID NO: 70.